Evidence map›Paper›PMID 34884306›Full record

ArticleJournal of clinical medicine2021

One Year Assessment of the Hearing Preservation Potential of the EVO Electrode Array.

Nicolas Guevara, Cécile Parietti-Winkler, Benoit Godey, Valerie Franco-Vidal, Dan Gnansia, Marine Ardoint, Michel Hoen, Chadlia Karoui, Eric Truy, Christophe Vincent and 2 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nicolas GuevaraInstitut Universitaire de la Face et du Cou (University Institute of the Face and Neck), Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, 06000 Nice, France.
Cécile Parietti-WinklerService d'ORL et CCF, CHU Nancy, 54000 Nancy, France.
Benoit GodeyDepartment of Otolaryngology, Head Neck Surgery, University Hospital Ponchaillou, 35000 Rennes, France.ORCID 0000-0002-2625-8902
Valerie Franco-VidalEar, Nose, and Throat Department, Bordeaux University Hospital, 33000 Bordeaux, France.ORCID 0000-0002-2630-5414
Dan GnansiaResearch & Technology, Oticon Medical, Technologies and Gene Therapy for Deafness, Hearing Institute, Institut Pasteur/Inserm, 16096 Paris, France.ORCID 0000-0001-6957-975X
Marine ArdointResearch & Technology, Oticon Medical, Technologies and Gene Therapy for Deafness, Hearing Institute, Institut Pasteur/Inserm, 16096 Paris, France.
Michel HoenResearch & Technology, Oticon Medical, Technologies and Gene Therapy for Deafness, Hearing Institute, Institut Pasteur/Inserm, 16096 Paris, France.ORCID 0000-0003-2099-8130
Chadlia KarouiResearch & Technology, Oticon Medical, Technologies and Gene Therapy for Deafness, Hearing Institute, Institut Pasteur/Inserm, 16096 Paris, France.ORCID 0000-0003-4661-1731
Eric TruyService d'ORL, De Chirurgie Cervico-Faciale et D'audiophonologie, Hôpital Edouard Herriot, Hospices Civils de Lyon, Université de Lyon, 69000 Lyon, France.ORCID 0000-0002-1769-8623
Christophe VincentOtology and Oto-Neurology Department, Lille University Hospital, 59000 Lille, France.
Isabelle MosnierENT Department, Pitié Salpêtrière Hospital, APHP/Sorbonne Université, 75013 Paris, France.
Yann NguyenENT Department, Pitié Salpêtrière Hospital, APHP/Sorbonne Université, 75013 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA prospective longitudinal multicentre study was conducted to assess the one-year postsurgical hearing preservation profile of the EVO

methodsFifteen adults presenting indications of electro-acoustic stimulation (pure-tone audiometry (PTA) thresholds ≤70 dB below 750 Hz) were implanted with the EVO™ electrode array. Hearing thresholds were collected at five time-points from CI activation to twelve months (12M) after activation. Hearing thresholds and hearing preservation profiles (HEARRING group classification) were assessed.

resultsAll subjects had measurable hearing thresholds at follow-up. No case of complete loss of hearing or minimal hearing preservation was reported at any time point. At activation (N

conclusionsThis study provides the first longitudinal follow-up on associated hearing profiles to the EVO™ electrode array, which are comparable to the literature. However, other studies on larger populations should be performed.

Indexed as

cochlear implantationEVO electrode arrayfunctional hearinghearing preservationHEARRING classification

Identifiers

PMID34884306
PMCPMC8658238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.